BioCentury
ARTICLE | Financial News

Ascletis ends first trading week on downturn

August 3, 2018 5:36 PM UTC

Ascletis Pharma Inc. (HKSE:1672) sank HK$1.84 (16%) to HK$10.02 on Friday, ending its first week of trading down 28% from its IPO price of HK$14.

This week, Ascletis became the first biotech to go public on the Hong Kong exchange since Hong Kong Exchanges and Clearing Ltd. (HKEX) created a new prerevenue chapter, opening the door for biotechs to list (see "First Out the Gate")...